Internal Medicine, Pulmonary Disease · Kansas City, MO
NPI
1861493934
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4321 Washington St, Suite 6000
Kansas City, MO, 64111
Phone (816) 756-2255
Groups this clinician bills Medicare through
Medicare paid, 2024
$92K
1,836 services
Medicare patients, 2024
471
Average age 73
Drug cost, 2024
$5.4M
2,695 prescriptions
Company payments, 2025
$17.38
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark B Yagan was code 99214 (office e&m - established), 290 times for 168 patients. In total Mark B Yagan billed 1,836 services in 30 codes, and Medicare paid $92K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 290 | 168 | $90.84 | $26K |
| 94729 Pulmonary Function Testing | Office | 284 | 270 | $35.88 | $10K |
| 94726 Pulmonary Function Testing | Office | 273 | 259 | $36.61 | $9,994 |
| 94010 Pulmonary Function Testing | Office | 195 | 180 | $17.11 | $3,336 |
| 99215 Office E&M - Established | Office | 173 | 110 | $126.13 | $22K |
| 94060 Pulmonary Function Testing | Office | 142 | 138 | $26.48 | $3,760 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 125 | 85 | $12.60 | $1,575 |
| 94618 Pulmonary Function Testing | Office | 83 | 68 | $23.32 | $1,936 |
| 99443 Telephone Services | Office | 33 | 30 | $94.42 | $3,116 |
| 99213 Office E&M - Established | Office | 28 | 25 | $59.42 | $1,664 |
| 99205 Office E&M - New | Office | 24 | 24 | $154.39 | $3,705 |
| 83050 Blood Count | Office | 22 | 21 | $8.04 | $177 |
| 82805 Clinical Chemistry | Office | 22 | 21 | $77.19 | $1,698 |
| 82375 Clinical Chemistry | Office | 22 | 21 | $12.07 | $266 |
| 85018 Blood Count | Office | 22 | 21 | $2.32 | $51.04 |
By year: 2022 $100K for 1,718 services; 2023 $92K for 1,624 services; 2024 $92K for 1,836 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36600 General Laboratory | 22 | 21 | $20.70 | $455 |
| 82375 Clinical Chemistry | 22 | 21 | $12.07 | $266 |
| 82805 Clinical Chemistry | 22 | 21 | $77.19 | $1,698 |
| 83050 Blood Count | 22 | 21 | $8.04 | $177 |
| 85018 Blood Count | 22 | 21 | $2.32 | $51.04 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark B Yagan prescribed most often to Medicare patients was Prednisone, with 319 prescriptions and refills. In total Mark B Yagan wrote 2,695 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 319 | 474 | 100 | $1,346 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 180 | 270 | 71 | $6,075 |
| Montelukast Sodium Generic | 134 | 311 | 33 | $1,660 |
| Sildenafil Citrate Generic | 114 | 215 | 28 | $18K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 107 | 171 | 23 | $108K |
| Azithromycin Generic | 104 | 130 | 49 | $540 |
| Furosemide Generic | 99 | 166 | 23 | $474 |
| Fluticasone Propionate Generic | 98 | 180 | 36 | $1,759 |
| Potassium Chloride Generic | 84 | 153 | 17 | $2,123 |
| Breo Ellipta Fluticasone/Vilanterol | 84 | 99 | 13 | $39K |
| Opsumit Macitentan | 81 | 81 | Under 11 | $1.0M |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 80 | 107 | 12 | $48K |
| Ambrisentan Generic | 73 | 73 | Under 11 | $171K |
| Orenitram Er Treprostinil Diolamine | 67 | 67 | Under 11 | $833K |
| Ofev Nintedanib Esylate | 61 | 61 | Under 11 | $569K |
Brand drugs: - claims; generic drugs: 1,638 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark B Yagan $17.38 ($17.38 in general payments such as food, travel and fees) from 2 companies. The largest payer was Insmed, Inc. with $17.38.
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. INSM | 1 | $17.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.